Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Microbiota Research in Iran; Current Knowledge and Future Perspective Publisher



Ejtahed HS1, 2 ; Hasaniranjbar S2 ; Soroush AR2 ; Siadat SD1, 3 ; Larijani B1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Mycobacteriology and Pulmonary Research, Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2021


Abstract

Objective: As the gut microbiota has attracted considerable attention in recent years, the aim of the present study is introducing a new microbiota research group at Endocrinology and Metabolism Research Institute (EMRI) that collaborates with national and international research centers for microbiome research projects management. Methods: All the documents from EMRI focused on the microbiota field were collected using PubMed, Scopus, and Web of Science electronic databases from the inception up to June 2020. Results: Findings of the EMRI research projects on the microbiota field were reviewed in this study and we highlighted some specific primary results of gut microbiota composition in the Iranian population. Moreover, applications of the developed Microbiota Database are introduced. Conclusion: Enhancement of investment in this field and interdisciplinary collaborations are needed to progress our knowledge about the Iranian gut microbiota composition and develop microbiota modulating interventions over the next decade. © 2021, Springer Nature Switzerland AG.
Other Related Docs
10. Gut Microbiota-Derived Metabolites in Obesity: A Systematic Review, Bioscience of Microbiota# Food and Health (2020)
11. Gut Microbiota Composition in Obese and Normal Weight Adults in Iran, Journal of Mazandaran University of Medical Sciences (2021)
15. Neuromodulatory Effect of Microbiome on Gut-Brain Axis; New Target for Obesity Drugs, Journal of Diabetes and Metabolic Disorders (2019)
20. The Role of Intestinal Microbiota in Cognitive Disorders, Journal of Mazandaran University of Medical Sciences (2021)
21. Trimethylamine N-Oxide As a Potential Risk Factor for Non-Communicable Diseases: A Systematic Review, Endocrine# Metabolic and Immune Disorders - Drug Targets (2023)
22. The Role of Probiotics on Controlling Diabetes Mellitus: An Umbrella Review, Journal of Mazandaran University of Medical Sciences (2021)
24. The Microbiome in Precision Medicine: A New Approach to Cancer Treatment, Journal of Mazandaran University of Medical Sciences (2021)
28. Diabetes Management by Probiotics: Current Knowledge and Future Perspectives, International Journal for Vitamin and Nutrition Research (2016)
32. Ethical Challenges in Conducting and the Clinical Application of Human Microbiome Research, Journal of Medical Ethics and History of Medicine (2023)
34. Targeting Tmao and Its Metabolic Pathway for Cardiovascular Diseases Treatment, Journal of Diabetes and Metabolic Disorders (2021)